ATRAptarGroup, Inc.

$135.23

Is the price fair?

What ATR's price assumes

AptarGroup, Inc. trades at 24.4× earnings against 42.5× for the median Medical Instruments & Supplies name, cheaper than its own group.

24.4

Trailing P/E · Medical Instruments & Supplies median 42.5 · cheaper than the typical name in its group

Price / sales
2.10

Price / sales · as of 2026-Q1

Free cash flow yield
4.0%

Free cash flow yield · Medical Instruments & Supplies median 3.7%

Growth the price implies
+8.5%

Growth the price implies · The price pays for +8.5% free cash flow growth a year for a decade; the business has delivered +23% a year over the last three.

Details
Price / book2026-Q1
3.09
Healthcare median P/E362 names
31.5
Medical Instruments & Supplies median P/E29 names
42.5
Free cash flow, trailing twelve months
$310M
Market capitalisation
$7.68B
3-year revenue growth
+5.1%
3-year free cash flow growth
+23%
What the market has paid for these earnings: 38 quarters of its own multiple × $5.54 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$140.80
Its own P/E history, median$162.14
Its own P/E history, upper quartile$172.81
52-week range$111.94 – $145.15
Today$135.23

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.